Abstract
Full text available
Keywords: Chitotriosidase, Alzheimer's disease, macrophage
Current Alzheimer Research
Title: Chitotriosidase and Alzheimers Disease
Volume: 4 Issue: 3
Author(s): Stefano Sotgiu, M.R. Piras, Rita Barone, Giannina Arru, M.L. Fois, Giulio Rosati and Salvatore Musumeci
Affiliation:
Keywords: Chitotriosidase, Alzheimer's disease, macrophage
Abstract: Full text available
Export Options
About this article
Cite this article as:
Stefano Sotgiu , M.R. Piras , Rita Barone , Giannina Arru , M.L. Fois , Giulio Rosati and Salvatore Musumeci , Chitotriosidase and Alzheimers Disease, Current Alzheimer Research 2007; 4 (3) . https://dx.doi.org/10.2174/156720507781077232
DOI https://dx.doi.org/10.2174/156720507781077232 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial [Hot Topic: Cognition Therapeutics (Guest Editor: Miao-Kun Sun)]
Current Drug Targets - CNS & Neurological Disorders Hypoxic Preconditioning Ameliorates Amyloid-β Pathology and Longterm Cognitive Decline in AβPP/PS1 Transgenic Mice
Current Alzheimer Research Targeting the Progression of Parkinsons Disease
Current Neuropharmacology Complex Atheromatosis of the Aortic Arch in Cerebral Infarction
Current Cardiology Reviews Diagnoses of Pathological States Based on Acetylcholinesterase and Butyrylcholinesterase
Current Medicinal Chemistry Cholesterol and Apoe: A Target for Alzheimers Disease Therapeutics
Current Drug Targets - CNS & Neurological Disorders Neurodegeneration in Amygdala Precedes Hippocampus in the APPswe/ PS1dE9 Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Approaching Neurological Diseases to Reduce Mobility Limitations in Older Persons
Current Pharmaceutical Design Protection Mechanisms Against Aβ42 Aggregation
Current Alzheimer Research The Importance of NAD in Multiple Sclerosis
Current Pharmaceutical Design The Role of Cannabinoids in Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke
Current Drug Targets A Scientific Approach to Anti-Ageing Therapies: State of the Art
Current Pharmaceutical Design CRISPR/Cas9 in Stem Cell Research: Current Application and Future Perspective
Current Stem Cell Research & Therapy Current Clinical Applications of In Vivo Magnetic Resonance Spectroscopy and Spectroscopic Imaging
Current Medical Imaging Editorial: In Silico Methodologies Applied to Drug Discovery
Combinatorial Chemistry & High Throughput Screening Metabolic Programming Nowadays (or Perhaps Now and then?)
Current Nutrition & Food Science The Role of Type 2 Fibroblast Growth Factor in Periodontal Therapy
Current Drug Targets Cognitive Function and the Ageing Process: The Peculiar Role of Mild Thyroid Failure
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Inhibition of microRNA-155 Alleviates Cognitive Impairment in Alzheimer’s Disease and Involvement of Neuroinflammation
Current Alzheimer Research Mineralocorticoid Antagonists in ESRD: An Overview of Clinical Trial Evidence
Current Vascular Pharmacology